Patent details

Basic Information

Publication number:

EP2540349

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121815336

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN COMPOSÉ DE QUINOXALINE MACROCYCLIQUE QUI EST UN INHIBITEUR DE LA PROTÉASE HCV NS3

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINER MAKROCYCLISCHEN CHINOXALINVERBINDUNG, DIE EIN HCV-NS3-PROTEASEHEMMER IST

SPC Number:

Dates

Filing date:

17/07/2009

Grant date:

12/02/2014

EP Publication Date:

12/02/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/01/2013

EP B1 Publication Date:

12/02/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/07/2014

Expiration date:

17/07/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/04/2014

 

 

Name:

MSD Italia S.r.l.

Address:

Via Vitorchiano, 151, 00189 Rome, Italy (IT)

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, 07065-0907, Rahway, NJ, United States (US)

Inventor

1

Name:

Liverton Nigel J.

Address:

United States (US)

2

Name:

Harper Steven

Address:

Italy (IT)

3

Name:

Summa Vincenzo

Address:

Italy (IT)

4

Name:

McCauley John A.

Address:

United States (US)

Priority

Priority Number:

135559 P

Priority Date:

22/07/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 31/14;

Filing date	Document type	Number of pages